Ads
related to: docetaxel long term use indications for treatment pdf template
Search results
Results From The WOW.Com Content Network
Docetaxel (DTX or DXL), sold under the brand name Taxotere among others, is a chemotherapy medication used to treat a number of types of cancer. [6] This includes breast cancer, head and neck cancer, stomach cancer, prostate cancer and non-small-cell lung cancer. [7]
TCH is a chemotherapy regimen consisting of Taxotere (docetaxel), carboplatin and Herceptin (trastuzumab), which is used to treat breast cancer. References [ edit ]
Mechanism of action of taxanes. The principal mechanism of action of the taxane class of drugs is the disruption of microtubule function. Microtubules are essential to cell division, and taxanes stabilize GDP-bound tubulin in the microtubule, thereby inhibiting the process of cell division as depolymerization is prevented.
By conducting a meta-analysis of four large breast cancer trials including nearly 3,000 patients, the researchers have discovered that an abnormality on chromosome 17, called CEP17, is associated with a worse outcome for patients, but also that its presence is a highly significant indicator that the tumor will respond to anthracyclines.
In the TH-302 plus docetaxel or pemetrexed treatment arms of the trial, 32 patients with non-small cell lung cancer were treated: Median PFS was 4.2 months. 24 January 2011 [ 25 ] [ 26 ] In the gemcitabine plus TH-302 treatment arms, 47 patients with advanced or metastatic pancreatic cancer were treated: Median progression free survival was 5.9 ...
The term was coined in the early 1900s by Paul Ehrlich as meaning any use of chemicals to treat any disease (chemo-+ -therapy), such as the use of antibiotics (antibacterial chemotherapy). [194] Ehrlich was not optimistic that effective chemotherapy drugs would be found for the treatment of cancer. [ 194 ]
The opposite of an indication is a contraindication, [4] a reason to withhold a certain medical treatment because the risks of treatment clearly outweigh the benefits. In the United States, indications for prescription drugs are approved by the FDA. Indications are included in the Indications and Usage section of the Prescribing Information.
Use of an inhibitor that blocks the interaction of PD-L1 with the PD-1 receptor can prevent the cancer from evading the immune system in this way. [9] Several PD-1 and PD-L1 inhibitors are being trialled within the clinic for use in advanced melanoma, non-small cell lung cancer, renal cell carcinoma, bladder cancer and Hodgkin lymphoma, amongst ...